| Natalia Lukankina, MD | |
|
111 Brewster St, Pawtucket, RI 02860-4400 | |
| (401) 729-6200 | |
| Not Available |
| Full Name | Natalia Lukankina |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 111 Brewster St, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043466154 | NPI | - | NPPES |
| Entity Name | Rhode Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861420333 PECOS PAC ID: 8921900044 Enrollment ID: O20040121000169 |
News Archive
Researchers from the University of Virginia have established new guidelines for scientists mapping out the body molecule by molecule to help us better understand how our cells use metals such as iron and magnesium to maintain good health.
Older adults may still be checking into hospitals for weeks after a natural disaster, past the expected three days of anticipated injuries and health issues, a new University of Michigan study shows.
Researchers at the Ruhr-Universität Bochum have debunked the theory that the left brain hemisphere is dominant in the processing of all languages. To date, it has been assumed that that dominance is not determined by the physical structure of a given language. However, the biopsychologists have demonstrated that both hemispheres are equally involved in the perception of whistled Turkish.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
St. Jude Medical, Inc. a global medical device company, today announced that its Board of Directors has authorized an additional share repurchase program of up to $300 million of its outstanding common stock.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalia Lukankina, MD 111 Brewster St, Pawtucket, RI 02860-4400 Ph: (401) 729-6200 | Natalia Lukankina, MD 111 Brewster St, Pawtucket, RI 02860-4400 Ph: (401) 729-6200 |
News Archive
Researchers from the University of Virginia have established new guidelines for scientists mapping out the body molecule by molecule to help us better understand how our cells use metals such as iron and magnesium to maintain good health.
Older adults may still be checking into hospitals for weeks after a natural disaster, past the expected three days of anticipated injuries and health issues, a new University of Michigan study shows.
Researchers at the Ruhr-Universität Bochum have debunked the theory that the left brain hemisphere is dominant in the processing of all languages. To date, it has been assumed that that dominance is not determined by the physical structure of a given language. However, the biopsychologists have demonstrated that both hemispheres are equally involved in the perception of whistled Turkish.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
St. Jude Medical, Inc. a global medical device company, today announced that its Board of Directors has authorized an additional share repurchase program of up to $300 million of its outstanding common stock.
› Verified 3 days ago
Tanya Jean Becker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 126 Prospect St, Pawtucket, RI 02860 Phone: 401-728-9206 Fax: 401-722-6960 | |
Dr. Karla Fuentes Kiker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 42 Park Pl, Pawtucket, RI 02860 Phone: 401-722-0081 Fax: 401-312-0318 | |
Viren Andrew D'sa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 555 Prospect St, Pawtucket, RI 02860 Phone: 401-729-6200 Fax: 401-729-6203 | |
Esther J. Entin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 111 Brewster St, Department Of Pediatrics, Pawtucket, RI 02860 Phone: 401-729-6200 Fax: 401-729-6203 | |
Kunjbala Sharma, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1145 Main St, Pawtucket, RI 02860 Phone: 401-722-0081 Fax: 401-312-0318 | |
Stephanie G Lawrence, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 21 Division St, Pawtucket, RI 02860 Phone: 401-727-4800 |